The New York Entrepreneur

FTC sues drug middlemen for allegedly inflating insulin prices

Read Time:7 Second

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Nike’s stock has been dogged by these issues. Can a new CEO change the game?
Next post Trump Media & Technology Group’s stock hits low as insider stock-sale ban lifts